Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

The letter was not a net net negative.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
conix Member Profile
 
Followed By 177
Posts 28,365
Boards Moderated 12
Alias Born 10/10/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2020 9:40:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2020 9:38:20 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2020 9:33:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2020 9:31:07 AM
CEL-SCI Awarded European Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis Business Wire - 9/18/2020 9:00:00 AM
CEL-SCI Corporation Issues Letter to Shareholders Business Wire - 9/15/2020 9:15:00 AM
CEL-SCI Corporation to Present at H.C. Wainwright 22nd Annual Global Investment Conference Business Wire - 9/11/2020 9:00:00 AM
CEL-SCI Corporation Reports Third Quarter Fiscal 2020 Financial Results Business Wire - 8/11/2020 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 5:27:09 PM
CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment Business Wire - 7/24/2020 8:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/13/2020 6:03:54 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 7/2/2020 5:39:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2020 10:37:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2020 10:36:13 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2020 10:34:55 AM
CEL-SCI Corporation Receives $10 Million Through Warrant Exercises Business Wire - 6/30/2020 8:30:00 AM
CEL-SCI to Present at H.C. Wainwright Virtual Fireside Chat Series Business Wire - 6/24/2020 10:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/26/2020 5:24:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 5:23:10 PM
CEL-SCI Corporation Reports Second Quarter Fiscal 2020 Financial Results Business Wire - 5/11/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2020 5:04:18 PM
CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of He... Business Wire - 5/4/2020 7:15:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/24/2020 5:50:15 PM
CEL-SCI Reports Recent Data Review by the Independent Data Monitoring Committee for Its Pivotal Phase 3 Head & Neck Cancer St... Business Wire - 4/23/2020 9:15:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/21/2020 6:01:11 AM
conix   Thursday, 02/27/20 01:31:24 PM
Re: fung_derf post# 29267
Post # of 33987 
The letter was not a net net negative.

The share price was susceptible for profit taking when you consider what was going on in the overall markets. If you have been around the markets for any length of time, which you are not shy about telling everyone, you would agree that when investors start raising cash in a rush, they can rotate to taking profits in stocks that have held up during the broader market decline. CVM had held up amazingly well -- until cash raising hit.

Market makers see the Limit GTC Buy orders. And if these orders get overwhelmed by selling, the market makers back off in times like these. For a few minutes or hours.

Stop loss orders may have contributed to the selling panic.

Anyone who has been in CVM over the past year have been happy up to a couple of days ago.

What do you sell if you want to mitigate your portfolio's market risk?

Do you sell a stock that has already gone down 20-25% from recent highs? OR do you sell an unprofitable biotech play that is still near its highs? (again --a couple of days ago)

Coupled with the "Sell now. Confirm info later" atmosphere and very reasonable risk that CVM field trial results may not come in as expected, you have quick decisions to sell that further overwhelm active buy orders to sop up the temporary over supply of sell orders.

JMO

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences